RNASEH2A and breast cancer: Meanwhile, the expression of ESPL1, IQGAP3, RNASEH2A, AURKA, PRR11, PRC1, GAS2L3, CDCA8, and CEP55 was not significantly associated with the adverse prognosis of BC patients (Figure S1).